Atlantic Biomedical Marks Its Debut at World Health Expo Dubai 2026
World Health Expo (formerly Arab Health) continues to serve as one of the most influential global platforms for healthcare innovation, bringing together industry leaders, manufacturers, clinicians, and decision-makers from across the world.
From 9–12 February 2026, at the Dubai Exhibition Centre, Atlantic Biomedical proudly made its first-ever participation at the event — a significant milestone in the company’s global growth journey.
Located at Booth N21.L91, the company showcased its comprehensive haemodialysis care portfolio to an international audience of hospital leaders, dialysis specialists, distributors, and healthcare partners.
A Strategic Global Step
Atlantic Biomedical’s debut participation marked more than just a trade show presence. It represented a strategic move toward expanding global engagement in dialysis safety, disinfection systems, and renal care solutions.
With a focused portfolio spanning:
- Haemodialysis concentrate solutions and dry powder
- Sodium bicarbonate bag and cartridge
- Dialysis disinfectants and sterilants
- Dialyzer reprocessing system
- Automatic mixing system
- Surface disinfection solution
- Calcium acetate tablets
The company demonstrated its commitment to delivering integrated dialysis care systems built around safety, precision, and clinical reliability.
The response from international visitors highlighted a growing demand for dependable, compliance-aligned dialysis solutions from trusted manufacturing partners.
Showcasing Clinical Confidence
Throughout the four-day exhibition, Atlantic Biomedical engaged with:
- Hospital administrators and procurement leaders
- Dialysis centre operators
- Nephrology professionals
- Global distribution partners
Discussions centred around infection prevention, operational efficiency, sustainability in dialysis processes, and the need for validated, dialysis-specific formulations.
The participation reinforced the company’s positioning as a specialised dialysis solutions provider operating under EU CE Compliance Certification (CE 0123) issued by TÜV SÜD, Munich, Germany, and ISO 13485-certified standards, with a strong emphasis on environmental responsibility.
Leadership Perspective
“Our first participation at World Health Expo Dubai marks an important milestone for Atlantic Biomedical. The global dialysis community is evolving rapidly, and platforms like this allow us to engage in meaningful discussions around safety, standardisation, and sustainability. We also had the opportunity to showcase our indigenously developed sodium bicarbonate bags – Renabag, and sodium bicarbonate cartridges – Renacart. We were encouraged by the strong interest in our integrated dialysis care portfolio and the opportunities for long-term international collaboration.”
— Mr. Ravi Vazirani, Director
“This exhibition was not just about showcasing products; it was about building relationships. We believe dialysis safety requires consistent systems, validated processes, and trusted partners. Our presence at World Health Expo reflects our commitment to responsible global growth while maintaining the highest clinical standards.
We were pleased to welcome visitors from Thailand, Indonesia, Vietnam, Qatar, UAE, Lebanon, Tanzania, Kazakhstan, South Africa, Yemen, Kenya, Bulgaria, Sri Lanka, Israel, Philippines, Turkey, Uzbekistan, Rwanda, Ethiopia, Moldova, Iran, Saudi Arabia, Jordan, Burundi, Kuwait, and Oman. It was encouraging to meet interested stakeholders from across regions and explore opportunities in new markets.
The exhibition enabled a healthy exchange of ideas to advance the dialysis industry, and we look forward to building meaningful collaborations with potential partners worldwide.”
— Mr. Varun Ravi Vazirani, Director
Strengthening Global Engagement
Atlantic Biomedical’s participation at World Health Expo Dubai 2026 signals the beginning of deeper global engagement initiatives. The company aims to build strategic distribution partnerships, support dialysis centres with scalable solutions, and continue investing in innovation within the renal care ecosystem.
The company has been exporting to the Ministry of Health, Mauritius, for over 30 years and has established its presence in Bhutan, Nepal, Ethiopia, Nigeria, Bamako, Tanzania, South Africa, Madagascar, Somalia, and Indonesia, reinforcing its long-standing international credibility and trusted partnerships.
As healthcare systems worldwide prioritise infection control, process efficiency, and sustainable practices, Atlantic Biomedical remains focused on delivering solutions that protect patients, support clinicians, and simplify operational workflows.
About Atlantic Biomedical
Atlantic Biomedical is a specialised manufacturer of haemodialysis care solutions, offering a comprehensive portfolio including concentrates, dry powder, disinfectants, reprocessing systems, mixing systems, and related renal care products. The company operates under EU CE Compliance Certification (CE 0123) issued by TÜV SÜD, Munich, Germany, and ISO 13485-certified standards, and is committed to delivering clinically reliable and environmentally responsible dialysis solutions.
Partner with us to shape the future of dialysis care.